RNA Past Earnings image   This RNA past earnings page last updated 11/10/2022
RNA Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/8/2022-0.820
Q2 20228/9/2022-0.920
Q1 20225/10/2022-0.710
Q4 20213/1/2022-0.820
Q3 202111/9/2021-0.680
Q2 20218/9/2021-0.700
Q1 20215/12/2021-0.640
Q4 20203/15/2021-0.430
Q3 202011/10/2020-0.310
Q2 20208/10/2020-1.230
RNA Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/8/20220.00B
Q2 20228/9/20220.00B
Q1 20225/10/20220.00B
Q4 20213/1/20220.00B
Q3 202111/9/20210.00B
Q2 20218/9/20210.00B
Q1 20215/12/20210.00B
Q4 20203/15/20210.00B
Q3 202011/10/20200.00B
Q2 20208/10/20200.00B
Quotes delayed 20 minutes

Email EnvelopeFree RNA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Avidity Biosciences (RNA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

RNAZ Past Earnings
RNXT Past Earnings
RPHM Past Earnings
RPID Past Earnings
RPRX Past Earnings
RSLS Past Earnings
RUBY Past Earnings
RVMD Past Earnings
RVNC Past Earnings
RVPH Past Earnings

RNA Past Earnings Q&A

What was the best and worst RNA past earnings results?
For Avidity Biosciences, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest RNA past earnings result in our data set was -0.310/share posted in Q3 2020, while the lowest was in Q2 2020 when RNA posted -1.230/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2021 when RNA reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q2 2020 at 0.00B of revenue.

  Suggested answer: There are 10 RNA past earnings results in our data set.

On this page we presented the RNA past earnings date information for Avidity Biosciences. Reviewing that RNA Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2020, when RNA posted gaap of -0.310/share. Meanwhile the lowest RNA past earnings result was in Q2 2020, when RNA posted gaap of -1.230/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2021 when RNA reported 0.00B in revenue, while the smallest revenue quarter was Q2 2020 when RNA reported 0.00B in revenue.

Any self directed investor doing their due diligence on RNA or any other given stock can benefit from researching all of the Avidity Biosciences past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Avidity Biosciences past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RNA. Thanks for visiting, and the next time you need to research RNA past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Teledyne Technologies 13F Filers, Top Ten Hedge Funds Holding ENOR, TXN Historical Stock Prices.

 

RNA Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.